Regulation of prostaglandin receptors by prostaglandins and guanine nucleotides in frog erythrocytes. 1977

R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011894 Rana pipiens A highly variable species of the family Ranidae in Canada, the United States and Central America. It is the most widely used Anuran in biomedical research. Frog, Leopard,Leopard Frog,Lithobates pipiens,Frogs, Leopard,Leopard Frogs
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005459 Fluorides Inorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Sodium and stannous salts are commonly used in dentifrices. Fluoride

Related Publications

R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
January 1982, Journal of cyclic nucleotide research,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
June 1979, European journal of pharmacology,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
March 1982, Science (New York, N.Y.),
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
June 1993, Biochimica et biophysica acta,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
July 1986, Life sciences,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
January 1979, Advances in experimental medicine and biology,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
October 1980, Biochemical and biophysical research communications,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
May 1983, Biochimica et biophysica acta,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
September 1982, Molecular pharmacology,
R J Lefkowitz, and D Mullikin, and C L Wood, and T B Gore, and C Mukherjee
May 1980, European journal of pharmacology,
Copied contents to your clipboard!